ICICI Prudential US Bluechip Equity Fund - Growth - Regular Plan

  • Previous Nav

  • Net Change on 11-06-2025

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The investment objective of ICICI Prudential US Bluechip Equity Fund is to provide long term capital appreciation to investors by primarily investing in equity and equity related securities of companies listed on recognized stock exchanges in the United States of America. The Scheme shall also invest in ADRs/GDRs issued by Indian and foreign companies.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
ICICI Prudential US Bluechip Equity Fund - Growth 67.19 0.32 8.52 15.18 12.63 15.23
NIFTY 50 - TRI N/A N/A N/A N/A N/A N/A
S&P 500 6.69 7.56 12.65 15.67 13.61 8.00

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
ICICI Prudential US Bluechip Equity Fund - Growth Jul 06, 2012 8.52 15.18 12.63 2.02 3,015.47
Motilal Oswal S&P 500 Index Fund - Regular Plan Growth Apr 28, 2020 14.94 18.07 15.96 1.13 3,545.28
Nippon India US Equity Opportunites Fund- Growth Plan- Growth Option Jul 23, 2015 12.27 17.81 13.01 2.39 674.95
Nippon India Japan Equity Fund- Growth Plan- Growth Option Aug 26, 2014 12.63 11.59 6.84 2.45 272.09

Fund Holdings as on 31-May-2025

  • Veeva Systems Inc

  • West Pharmaceutical Services Inc

  • Huntington Ingalls Industries Inc

  • Brown-Forman Corp

  • Allegion plc

  • Zimmer Biomet Holdings Inc

  • Microchip Technology Inc.

  • Pfizer Inc

  • Monolithic Power Systems Inc

  • Corteva Inc

  • GE HealthCare Technologies Inc

  • Campbell Soup Co

  • US Bancorp Inc

  • Walt Disney

  • Boeing Co

  • MarketAxess Holdings Inc

  • Alphabet Inc

  • Nike Inc

  • Adobe Inc

  • Agilent Technologies Co Ltd

  • Estee Lauder Cos Inc

  • Danaher Corp

  • NXP Semiconductors NV

  • International Flavors & Fragrances Inc

  • TRANSUNION

  • Constellation Brands Inc

  • United Parcel Service Inc

  • Bio-Rad Laboratories Inc

  • Net Current Assets

  • Microsoft Corp

  • Mondelez International Inc

  • Amgen Inc

  • Charles Schwab Corp

  • Synopsys Inc

  • Oracle Corp

  • Bristol-Myers Squibb Co

  • Thermo Fisher Scientific Inc

  • Amazon com

  • Merck & Co Inc

  • Manhattan Associates Inc

  • Northrop Grumman Corp

  • Equifax Inc.

  • Lam Research Corporation

  • Gilead Sciences Inc.

  • Masco Corp.

  • Applied Material (US)

  • Autodesk

  • Biogen Inc

  • Cadence Design Systems Inc

  • Kenvue Inc

  • TERADYNE INC

  • Comcast Corporation

  • IDEX Corp

  • Salesforce.Com Inc

  • Occidental Petroleum Corp

  • Epam Systems Inc

  • Qualcomm Inc.

  • Freeport-McMoRan Inc

  • TREPS

  • Medtronic Plc

  • ASML Holding NV-NY REG SHS

  • Altria Group Inc

  • Yum China Holdings Inc.

View More
  • Miscellaneous

View More

Fund Manager

  • Cash

  • Equity

View More

About ICICI Prudential US Bluechip Equity Fund

Scheme Analysis

ICICI Prudential US Bluechip Equity Fund is a Equity - Thematic Fund - Global fund and belongs to ICICI Prudential Mutual Fund. It was launched on 06-Jul-2012 and currently has an AUM of ₹3,015.47 crore. ICICI Prudential US Bluechip Equity Fund is benchmarked against NIFTY 50 - TRI as primary index and S&P 500 as secondary index.

The NAV of ICICI Prudential US Bluechip Equity Fund ended down ₹-0.45(-0.72%)yesterday to ₹62.11.

Among its top 3 holdings the fund has exposure to Veeva Systems Inc, and

The ICICI Prudential US Bluechip Equity Fund is managed by Ritesh Lunawat and Sharmila Dmello.

Fund House Contact

One BKC, A - Wing 13th Floor, Bandra Kurla Complex, Bandra (East) Mumbai - 400 051

+91 (22) 2652 5000
enquiry@icicipruamc.com
+91 (22) 2652 8100